Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb Co shares valued at $100,000 were purchased by Hirawat Samit on Feb 14 ’25. At $54.84 per share, Hirawat Samit acquired 1,823 shares. The insider’s holdings grew to 63,932 shares worth approximately $3.57 million following the completion of this transaction.
Also, Holzer Phil M sold 700 shares, netting a total of over 38,930 in proceeds. Following the sale of shares at $55.62 each, the insider now holds 11,760 shares.
Before that, Hirawat Samit had added 1,830 shares to its account. In a trade valued at $100,055, the EVP,Chief Med.Offr.,Drug Dev. bought Bristol-Myers Squibb Co shares for $54.67 each. Upon closing the transaction, the insider’s holdings increased to 1,830 shares, worth approximately $3.47 million.
As published in a research note from Jefferies on December 16, 2024, Bristol-Myers Squibb Co [BMY] has been rated up from a Hold to a Buy and the price target has been revised to $70. As of November 15, 2024, Wolfe Research has initiated its “Peer perform” rating for BMY. Earlier on November 13, 2024, Daiwa Securities upgraded its rating. Their new recommendation was “an Outperform” for BMY stock which previously was a “a Neutral”.
Analyzing BMY Stock Performance
During the last five days, there has been a drop of approximately -0.64%. Over the course of the year, Bristol-Myers Squibb Co shares have dropped approximately -1.36%. Shares of the company reached a 52-week high of $61.10 on 01/27/25 and a 52-week low of $53.54 on 02/18/25. A 50-day SMA is recorded $57.14, while a 200-day SMA reached $50.58. Nevertheless, trading volume fell to 8.56 million shares from 10.77 million shares the previous day.
Support And Resistance Levels for Bristol-Myers Squibb Co (BMY)
According to the 24-hour chart, there is a support level at 55.12, which, if violated, would cause prices to drop to 54.45. In the upper region, resistance lies at 56.14. The next price resistance is at 56.49. RSI (Relative Strength Index) is 44.93 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.70, which suggests the price will decrease in the coming days. Percent R is at 67.01%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
